UBS Raises BILIBILI-W (09626.HK) Price Target to $314.9 Due to Improved Advertising Growth Prospects
Stock Performance: BILIBILI-W (09626.HK) experienced a decline of 2.248%, with short selling amounting to $94.49 million and a ratio of 11.851%.
Management Outlook: The company's management expressed confidence in 4Q25 performance aligning with expectations and highlighted positive advertising growth prospects for 2026, particularly from AI and gaming sectors.
Revenue Forecasts: UBS raised its revenue and profit forecasts for BILIBILI-W by 1% and 2% respectively, citing improved advertising growth expectations.
Target Price Increase: UBS increased the target prices for BILIBILI-W's H-shares and US stock, adjusting them from $279.9 to $314.9 and from $36 to $40.5, while maintaining a "Buy" rating.
Trade with 70% Backtested Accuracy
Analyst Views on 09626
About the author
HSI Rises 171 Points as BABA-W Jumps 2%; WUXI BIO Remains Steady
PBOC Measures: The People's Bank of China has lowered interest rates on various monetary policy tools, positively impacting the Hong Kong stock market, with the HSI, HSCEI, and HSTECH all opening higher.
Kuaishou and Other Tech Stocks: Kuaishou's stock rose 1.6% after issuing senior notes, while Alibaba and Tencent also saw gains, although some tech stocks like JD and Baidu experienced slight declines.
CKH Holdings Plans: CKH Holdings is planning to list A.S. Watson in Hong Kong and London by 2Q26, aiming for a valuation of $30 billion, which boosted its share price by 2.2%.
Wuxi Bio's Shareholder Action: Wuxi Biologics' stock fell 3.4% after its major shareholder sold shares at a discount, resulting in a significant cash-out of over $5.7 billion.
UBS Raises BILIBILI-W (09626.HK) Price Target to $314.9 Due to Improved Advertising Growth Prospects
Stock Performance: BILIBILI-W (09626.HK) experienced a decline of 2.248%, with short selling amounting to $94.49 million and a ratio of 11.851%.
Management Outlook: The company's management expressed confidence in 4Q25 performance aligning with expectations and highlighted positive advertising growth prospects for 2026, particularly from AI and gaming sectors.
Revenue Forecasts: UBS raised its revenue and profit forecasts for BILIBILI-W by 1% and 2% respectively, citing improved advertising growth expectations.
Target Price Increase: UBS increased the target prices for BILIBILI-W's H-shares and US stock, adjusting them from $279.9 to $314.9 and from $36 to $40.5, while maintaining a "Buy" rating.
HSI Closes with a 151-Point Gain; BABA-W Surges Over 5%; TRIP.COM-S Declines Over 6%
Trade Performance: Mainland China's exports rose 6.6% YoY and imports increased 5.7% in December, exceeding forecasts, while Hong Kong's stock market saw gains led by Alibaba's strong performance.
Stock Market Movements: The Hang Seng Index (HSI) opened higher, fluctuated throughout the day, and closed up 151 points at 26,999, with notable increases in technology stocks like Alibaba and Kuaishou.
Company Highlights: Alibaba's Qianwen surpassed 100 million monthly active users, while Kuaishou reported significant revenue growth. Other companies like Q TECH and ALI HEALTH also saw substantial stock price increases.
Market Challenges: Despite some gains, other tech stocks like Meituan and JD experienced declines, and travel platform Trip.com faced a significant drop due to an investigation by regulatory authorities.
BILIBILI-W Plans Complete Integration of AI Technology in Marketing This Year
Advertising Revenue Growth: BILIBILI-W's advertising revenue has seen over 20% growth for 11 consecutive quarters, attributed to high-quality content as of Q3 2025.
AI Integration in Marketing: The company plans to fully integrate AI technology into its marketing processes this year, enhancing its marketing performance and launching a self-service AI marketing strategy center for merchants.
BofA Securities' Updated Ratings and Price Targets for Chinese Internet Stocks (Table)
Stock Performance: Several stocks showed positive movements, with BABA-W increasing by 3.5% and ALI HEALTH by 3.3%, while BIDU-SW and JD HEALTH experienced declines of 1.4% and 1.2%, respectively.
Short Selling Data: Notable short selling activity was observed, particularly in BIDU-SW with a ratio of 28.7% and ALI HEALTH at 25.4%, indicating significant market interest in these stocks.
BofAS: AI Continues to Be the Key Growth Driver for China's Internet; TENCENT is the Top Sector Choice
Stock Performance Predictions: BofA Securities forecasts divergent stock performance in China's internet sector for the year, with AI expected to lead growth while macroeconomic conditions pressure consumer and corporate spending.
Investment Preferences: The report favors AI and online gaming stocks over e-commerce, highlighting TENCENT as the top pick for its AI-driven growth and stable market position, while BABA-W is recommended for its potential in AI and e-commerce.
Digital Entertainment Focus: In the digital entertainment space, BofA Securities recommends BILIBILI-W and TME-SW for their online gaming prospects, while also favoring JD HEALTH and TRIP.COM-S in their respective sectors.
Neutral Stance on Certain Stocks: The broker maintains a neutral outlook on Pinduoduo and Meituan, indicating a cautious approach towards these stocks amidst the current market conditions.
HSI Rises 171 Points as BABA-W Jumps 2%; WUXI BIO Remains Steady
PBOC Measures: The People's Bank of China has lowered interest rates on various monetary policy tools, positively impacting the Hong Kong stock market, with the HSI, HSCEI, and HSTECH all opening higher.
Kuaishou and Other Tech Stocks: Kuaishou's stock rose 1.6% after issuing senior notes, while Alibaba and Tencent also saw gains, although some tech stocks like JD and Baidu experienced slight declines.
CKH Holdings Plans: CKH Holdings is planning to list A.S. Watson in Hong Kong and London by 2Q26, aiming for a valuation of $30 billion, which boosted its share price by 2.2%.
Wuxi Bio's Shareholder Action: Wuxi Biologics' stock fell 3.4% after its major shareholder sold shares at a discount, resulting in a significant cash-out of over $5.7 billion.
UBS Raises BILIBILI-W (09626.HK) Price Target to $314.9 Due to Improved Advertising Growth Prospects
Stock Performance: BILIBILI-W (09626.HK) experienced a decline of 2.248%, with short selling amounting to $94.49 million and a ratio of 11.851%.
Management Outlook: The company's management expressed confidence in 4Q25 performance aligning with expectations and highlighted positive advertising growth prospects for 2026, particularly from AI and gaming sectors.
Revenue Forecasts: UBS raised its revenue and profit forecasts for BILIBILI-W by 1% and 2% respectively, citing improved advertising growth expectations.
Target Price Increase: UBS increased the target prices for BILIBILI-W's H-shares and US stock, adjusting them from $279.9 to $314.9 and from $36 to $40.5, while maintaining a "Buy" rating.
HSI Closes with a 151-Point Gain; BABA-W Surges Over 5%; TRIP.COM-S Declines Over 6%
Trade Performance: Mainland China's exports rose 6.6% YoY and imports increased 5.7% in December, exceeding forecasts, while Hong Kong's stock market saw gains led by Alibaba's strong performance.
Stock Market Movements: The Hang Seng Index (HSI) opened higher, fluctuated throughout the day, and closed up 151 points at 26,999, with notable increases in technology stocks like Alibaba and Kuaishou.
Company Highlights: Alibaba's Qianwen surpassed 100 million monthly active users, while Kuaishou reported significant revenue growth. Other companies like Q TECH and ALI HEALTH also saw substantial stock price increases.
Market Challenges: Despite some gains, other tech stocks like Meituan and JD experienced declines, and travel platform Trip.com faced a significant drop due to an investigation by regulatory authorities.
BILIBILI-W Plans Complete Integration of AI Technology in Marketing This Year
Advertising Revenue Growth: BILIBILI-W's advertising revenue has seen over 20% growth for 11 consecutive quarters, attributed to high-quality content as of Q3 2025.
AI Integration in Marketing: The company plans to fully integrate AI technology into its marketing processes this year, enhancing its marketing performance and launching a self-service AI marketing strategy center for merchants.
BofA Securities' Updated Ratings and Price Targets for Chinese Internet Stocks (Table)
Stock Performance: Several stocks showed positive movements, with BABA-W increasing by 3.5% and ALI HEALTH by 3.3%, while BIDU-SW and JD HEALTH experienced declines of 1.4% and 1.2%, respectively.
Short Selling Data: Notable short selling activity was observed, particularly in BIDU-SW with a ratio of 28.7% and ALI HEALTH at 25.4%, indicating significant market interest in these stocks.
BofAS: AI Continues to Be the Key Growth Driver for China's Internet; TENCENT is the Top Sector Choice
Stock Performance Predictions: BofA Securities forecasts divergent stock performance in China's internet sector for the year, with AI expected to lead growth while macroeconomic conditions pressure consumer and corporate spending.
Investment Preferences: The report favors AI and online gaming stocks over e-commerce, highlighting TENCENT as the top pick for its AI-driven growth and stable market position, while BABA-W is recommended for its potential in AI and e-commerce.
Digital Entertainment Focus: In the digital entertainment space, BofA Securities recommends BILIBILI-W and TME-SW for their online gaming prospects, while also favoring JD HEALTH and TRIP.COM-S in their respective sectors.
Neutral Stance on Certain Stocks: The broker maintains a neutral outlook on Pinduoduo and Meituan, indicating a cautious approach towards these stocks amidst the current market conditions.
